Lemaitre Vascular Inc Shares Climb 0.3% Past Previous 52-Week High - Market Mover
The shares rose 0.3% higher than its previous 52-week high of $54.81, with trading volume higher than its 30 day average
Jun 10, 2021 by Kwhen Finance Editors
- Trading volume this week was 13.3% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
|Name||DoD %Δ||YTD %Δ||1 Yr %||52-Week H %||52-Week L %|
|Lemaitre Vascular Inc||2.0||33.7||101.2||-1.5||131.5|
|Dow Jones Industrial Average||0.1||13.5||28.6||-1.1||41.9|
|S&P 500 Index||0.5||13.1||33.5||-0.1||44.8|
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 151.4%
- The company's stock price performance over the past 12 months beats the peer average by 268.0%
|Name||MKT CAP (USD)||P/E||YTD %Δ||1 Yr %Δ||52-Week H %||52-Week L %|
|Lemaitre Vascular Inc||LMAT||0||33.7||101.2||-1.5||131.5|
|Edwards Lifesciences Corp||EW||70.9||6.4||29.5||-0.9||46.8|
|Boston Scientific Corp.||BSX||297.8||17.7||10.6||-4.8||28.8|
|Baxter International Inc.||BAX||38.8||3.3||-4.2||-8.8||11.2|
|Cardiovascular Systems Inc.||CSII||-67.8||-10.1||2.5||-18.2||42.6|
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to email@example.com. © 2021 Kwhen Inc.
Was this content valuable for you?